On 2025-05-13, Bicara Therapeutics Inc. (BCAX) announced earnings per share of $-0.68 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.40.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.54 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-13 | 2025-03-31 | $-0.40 | $-0.68 |
2025-03-27 | 2024-12-31 | $-0.31 | $-0.39 |
2024-11-12 | 2024-09-30 | $-0.46 | $-1.60 |